188 related articles for article (PubMed ID: 33829916)
1. Analysis of Risk Factors in COVID-19 Adult Mortality in Russia.
Kirillov Y; Timofeev S; Avdalyan A; Nikolenko VN; Gridin L; Sinelnikov MY
J Prim Care Community Health; 2021; 12():21501327211008050. PubMed ID: 33829916
[TBL] [Abstract][Full Text] [Related]
2. Morbidity and mortality outcomes of COVID-19 patients with and without hypertension in Lagos, Nigeria: a retrospective cohort study.
Abayomi A; Osibogun A; Kanma-Okafor O; Idris J; Bowale A; Wright O; Adebayo B; Balogun M; Ogboye S; Adeseun R; Abdus-Salam I; Mutiu B; Saka B; Lajide D; Yenyi S; Agbolagorite R; Onasanya O; Erinosho E; Obasanya J; Adejumo O; Adesola S; Oshodi Y; Akase IE; Ogunbiyi S; Omosun A; Erinoso F; Abdur-Razzaq H; Osa N; Akinroye K
Glob Health Res Policy; 2021 Jul; 6(1):26. PubMed ID: 34325747
[TBL] [Abstract][Full Text] [Related]
3. Association between body-mass index, patient characteristics, and obesity-related comorbidities among COVID-19 patients: A prospective cohort study.
Tong L; Khani M; Lu Q; Taylor B; Osinski K; Luo J
Obes Res Clin Pract; 2023; 17(1):47-57. PubMed ID: 36577559
[TBL] [Abstract][Full Text] [Related]
4. Determinants of survival after severe acute respiratory syndrome coronavirus 2 infection in Mexican outpatients and hospitalised patients.
Prado-Galbarro FJ; Sanchez-Piedra C; Gamiño-Arroyo AE; Cruz-Cruz C
Public Health; 2020 Dec; 189():66-72. PubMed ID: 33166857
[TBL] [Abstract][Full Text] [Related]
5. Impact of diabetes on COVID-19-related in-hospital mortality: a retrospective study from Northern Italy.
Ciardullo S; Zerbini F; Perra S; Muraca E; Cannistraci R; Lauriola M; Grosso P; Lattuada G; Ippoliti G; Mortara A; Manzoni G; Perseghin G
J Endocrinol Invest; 2021 Apr; 44(4):843-850. PubMed ID: 32776197
[TBL] [Abstract][Full Text] [Related]
6. Hematological Parameters and Comorbidities in COVID-19: Insights into Clinical Profiles and Outcome Predictors.
Alsharif KF
Clin Lab; 2024 May; 70(5):. PubMed ID: 38747913
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D and COVID-19 severity and related mortality: a prospective study in Italy.
Campi I; Gennari L; Merlotti D; Mingiano C; Frosali A; Giovanelli L; Torlasco C; Pengo MF; Heilbron F; Soranna D; Zambon A; Di Stefano M; Aresta C; Bonomi M; Cangiano B; Favero V; Fatti L; Perego GB; Chiodini I; Parati G; Persani L
BMC Infect Dis; 2021 Jun; 21(1):566. PubMed ID: 34126960
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and characterization of asthma in hospitalized and nonhospitalized patients with COVID-19.
Chhiba KD; Patel GB; Vu THT; Chen MM; Guo A; Kudlaty E; Mai Q; Yeh C; Muhammad LN; Harris KE; Bochner BS; Grammer LC; Greenberger PA; Kalhan R; Kuang FL; Saltoun CA; Schleimer RP; Stevens WW; Peters AT
J Allergy Clin Immunol; 2020 Aug; 146(2):307-314.e4. PubMed ID: 32554082
[TBL] [Abstract][Full Text] [Related]
9. Chronic comorbidities and clinical outcomes in patients with and without COVID-19: a large population-based study using national administrative healthcare open data of Mexico.
Martos-Benítez FD; Soler-Morejón CD; García-Del Barco D
Intern Emerg Med; 2021 Sep; 16(6):1507-1517. PubMed ID: 33411264
[TBL] [Abstract][Full Text] [Related]
10. Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis.
Harrison SL; Fazio-Eynullayeva E; Lane DA; Underhill P; Lip GYH
PLoS Med; 2020 Sep; 17(9):e1003321. PubMed ID: 32911500
[TBL] [Abstract][Full Text] [Related]
11. Higher comorbidities and early death in hospitalized African-American patients with Covid-19.
Gupta R; Agrawal R; Bukhari Z; Jabbar A; Wang D; Diks J; Alshal M; Emechebe DY; Brunicardi FC; Lazar JM; Chamberlain R; Burza A; Haseeb MA
BMC Infect Dis; 2021 Jan; 21(1):78. PubMed ID: 33461499
[TBL] [Abstract][Full Text] [Related]
12. Hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care setting (LIBERTY): A structured summary of a study protocol for a randomised controlled trial.
Vainio PJ; Hietasalo P; Koivisto AL; Kääriäinen S; Turunen J; Virtala M; Vuorinen J; Scheinin M
Trials; 2021 Jan; 22(1):44. PubMed ID: 33430933
[TBL] [Abstract][Full Text] [Related]
13. Obesity and Mortality Among Patients Diagnosed With COVID-19: Results From an Integrated Health Care Organization.
Tartof SY; Qian L; Hong V; Wei R; Nadjafi RF; Fischer H; Li Z; Shaw SF; Caparosa SL; Nau CL; Saxena T; Rieg GK; Ackerson BK; Sharp AL; Skarbinski J; Naik TK; Murali SB
Ann Intern Med; 2020 Nov; 173(10):773-781. PubMed ID: 32783686
[TBL] [Abstract][Full Text] [Related]
14. Hypertension, Diabetes and Obesity, Major Risk Factors for Death in Patients with COVID-19 in Mexico.
Peña JE; Rascón-Pacheco RA; Ascencio-Montiel IJ; González-Figueroa E; Fernández-Gárate JE; Medina-Gómez OS; Borja-Bustamante P; Santillán-Oropeza JA; Borja-Aburto VH
Arch Med Res; 2021 May; 52(4):443-449. PubMed ID: 33380361
[TBL] [Abstract][Full Text] [Related]
15. Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study.
Ge E; Li Y; Wu S; Candido E; Wei X
PLoS One; 2021; 16(10):e0258154. PubMed ID: 34610047
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the demographic characteristics and comorbidities of patients with COVID-19 who died in Spanish hospitals based on whether they were or were not admitted to an intensive care unit.
Miró Ò; Alquézar-Arbé A; Llorens P; Martín-Sánchez FJ; Jiménez S; Martín A; Burillo-Putze G; Jacob J; García-Lamberechts EJ; Piñera P; Del Castillo JG;
Med Intensiva (Engl Ed); 2021; 45(1):14-26. PubMed ID: 33158594
[TBL] [Abstract][Full Text] [Related]
17. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.
Santos CS; Morales CM; Álvarez ED; Castro CÁ; Robles AL; Sandoval TP
Clin Rheumatol; 2020 Sep; 39(9):2789-2796. PubMed ID: 32720259
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 mortality effects of underlying health conditions in India: a modelling study.
Novosad P; Jain R; Campion A; Asher S
BMJ Open; 2020 Dec; 10(12):e043165. PubMed ID: 33328263
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of SARS-CoV-2 Infection in Patients With Chronic Liver Disease and Cirrhosis: A National COVID Cohort Collaborative Study.
Ge J; Pletcher MJ; Lai JC;
Gastroenterology; 2021 Nov; 161(5):1487-1501.e5. PubMed ID: 34284037
[TBL] [Abstract][Full Text] [Related]
20. Characteristics and outcomes of patients hospitalized for COVID-19 in France: The Critical COVID-19 France (CCF) study.
Bonnet G; Weizman O; Trimaille A; Pommier T; Cellier J; Geneste L; Panagides V; Marsou W; Deney A; Attou S; Delmotte T; Ribeyrolles S; Chemaly P; Karsenty C; Giordano G; Gautier A; Chaumont C; Guilleminot P; Sagnard A; Pastiero J; Ezzouhairi N; Perin B; Zakine C; Levasseur T; Ma I; Chavignier D; Noirclerc N; Darmon A; Mevelec M; Duceau B; Sutter W; Mika D; Fauvel C; Pezel T; Waldmann V; Cohen A;
Arch Cardiovasc Dis; 2021 May; 114(5):352-363. PubMed ID: 34154953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
